At Bradley Hospital in Providence, Rhode Island, researchers have cracked a puzzle that has kept one of anxiety's most powerful treatments locked away from countless patients: therapists' own fear. In a study published in JMIR Medical Education, scientists led by clinical psychologist Joshua Kemp demonstrated that virtual reality training can help therapists overcome their doubts about exposure therapy—making them more confident and willing to use it with their clients.
Exposure therapy stands as one of the most effective treatments for anxiety disorders, yet many qualified therapists avoid prescribing it. The culprit isn't lack of evidence or clinical skill. It's something more human: providers worry that facing their patients' fears head-on might overwhelm or traumatize them. These concerns, though well-intentioned, are often unfounded—but they persist nonetheless. Traditional classroom-based training exists to address these worries, but access is spotty, consistency is unpredictable, and delivering the same instruction everywhere remains a logistical challenge.
Kemp and his team at the Pediatric Anxiety Research Center designed what they call the "exposure to exposure" (E2E) framework—a clever name that captures the core idea. By putting therapists themselves into carefully constructed virtual scenarios, they allow providers to face their own anxieties about exposure therapy in a controlled, repeatable environment. "VR gives us a scalable way to offer consistent, hands-on practice," Kemp explained, noting his role as innovation officer at Brown University Health's Office of Research Administration. "Using our 'exposure to exposure' framework, we designed VR training to help therapists face their own worries about exposure therapy."
The research tested two different technological approaches. One used a head-mounted display—the immersive headset experience most people associate with virtual reality. The other relied on a regular desktop computer, a simpler setup that's far more accessible and affordable. The findings were striking: both versions worked equally well. The more expensive, elaborate headset offered no meaningful advantage over the straightforward desktop approach. This matters enormously for scaling. It suggests that therapists worldwide could gain confidence and shift their beliefs about exposure therapy using the kind of technology most clinical settings already possess.
What makes this study particularly significant is its timing and scope. It represents one of the first rigorous tests of how immersion level affects therapist training—a question that bridges neuroscience, education, and mental health access. The implications ripple outward quickly. If simpler VR systems can genuinely help therapists overcome their hesitations, then a major bottleneck in anxiety treatment begins to clear. Patients who might otherwise wait months or years for proper care could access evidence-based therapy far sooner.
The research team acknowledges the work's current limitations. They call for larger and more diverse studies to confirm these results and to explore how VR-based training translates into real-world shifts in clinical practice. But the direction is encouraging: a low-cost, scalable tool that meets therapists where their resistance lives—not in their knowledge, but in their uncertainty—and helps them step through it.